Patent ID: 11884725
Assignee: AMPSOURCE BIOPHARMA SHANGHAI INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. The method of claim 18, wherein:
(1) the tumor is selected from lung cancer, squamous cell lung cancer, melanoma, renal cancer, breast cancer, IM-TN breast cancer, colorectal cancer, leukemia or a metastatic lesion of the cancer;
(2) the infectious disease is selected from viral infection, bacterial infection, fungal infection and parasitic infection, including but not limited to, HIV, hepatitis virus, herpes virus or sepsis;
(3) the autoimmune disease is selected from rheumatoid arthritis, psoriasis, systemic lupus erythematosus, primary biliary cirrhosis, autoimmune hemolytic anemia, autoimmune thrombocytopenic purpura, insulin-dependent diabetes mellitus, Graves' disease, myasthenia gravis, autoimmune hepatitis and multiple sclerosis.